In a proteomics study involving the full spectrum of gastric lesions in GC progression, our team has reported that altered signatures of APOA1BP, PGC, HPX, and DDT in gastric tissues are associated with the risk of gastric lesion progression and GC occurrence28. This evidence concerns the gene NAXE and gastric cancer.